Skip to main content
. 2022 Jan 31;15:17562864221074144. doi: 10.1177/17562864221074144

Figure 5.

Figure 5.

Forest plots for the meta-analysis based on 90-day mRS scores in patients with prior ICrH versus patients without prior ICrH in studies using standard-dose IVT: (a) favorable outcomes (mRS, 0–1) and (b) unfavorable outcomes (mRS, 4–6).